The BMJ | The BMJ: leading general medical journal. Research. Education. Comment

Intended for healthcare professionals

Wellcome

Feature

Covid-19, trust, and Wellcome: how charity’s pharma investments overlap with its research efforts

The major funder of health research stands to gain financially from the pandemic, raising questions about transparency and accountability

Read our latest coverage of the coronavirus outbreak

Mexico

Feature

Covid-19 has made the obesity epidemic worse, but failed to ignite enough action

BMJ opinionCovid-19: We must tackle obesity and health inequalities in order to build back better

research data

Research paper

Treatment effects in randomised trials using routinely collected data for outcome assessment versus traditional trials

coronavirus vaccine trial

Editorial

Avoiding exploitation in multinational covid-19 vaccine trials

vitamin D

Editorial

Vitamin D and covid-19

More articles

News

Government’s new scientific research agency will be exempt from public contract rules and Freedom of Information Act

Minerva

Masks, humidity . . . and other stories

Editor's choice

Covid 19: Why we can’t risk another wave

News

Judge overturns decision to strike consultant surgeon off medical register

News

Covid-19: 237m vaccine doses to be distributed worldwide over next three months

Endgames

A boy with purpura on the legs

Minerva

Wolf’s post-herpetic isotopic response

Views & reviews

David Oliver: Has covid-19 shown society’s disregard for old and sick people?

News

Covid-19: Highest death rates seen in countries with most overweight populations

BMJ opinionWe must tackle obesity and health inequalities in order to build back better

News

Covid-19: Government pursued in the courts over controversial antibody test

FeatureTesting times for the government’s favoured antibody kit

PodcastWhy the government is being sued over PPE contract‪s

News

Portraits of the people who made vaccines possible

News

Seven days in medicine: 24 February to 2 March 2021

News

Covid-19: Germany struggles with slow uptake of Oxford AstraZeneca vaccine

News

Covid-19: Universities may need to test students every three days to prevent major outbreaks, say researchers

News

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance

Practice

Postpartum thyroiditis

Feature

NHS sickness absence during the covid-19 pandemic

News

Fabricated illness: guidance is updated as survey shows nearly all paediatricians see potential cases

News

Covid-19: Where are we on vaccines and variants?

News

Covid-19: Single dose of Pfizer and Oxford vaccines cuts risk of hospital admission by 80% in over 80s, data suggest

Views & reviews

Matt Morgan: Head, shoulders, knees, and toes—what’s next on the NHS waiting list?

Research paper

High flow oxygen and risk of mortality in patients with a suspected acute coronary syndrome

Analysis

Vitamin D supplementation and testing in the UK: costly but ineffective?

EditorialVitamin D and covid-19

Views & reviews

Helen Salisbury: Exposure risk is our next priority

Show more articles

Submit your paper

Editor's choice

Editor's choice

Covid 19: Why we can’t risk another wave

The BMJ latest issue cover

Print and app issue

Vitamin D supplementation and testing in the UK: costly but ineffective? | The BMJ

Covid-19: Pfizer vaccine efficacy was 52% after first dose and 95% after second dose, paper shows | The BMJ

Covid-19: How the UK is using lateral flow tests in the pandemic | The BMJ

Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval | The BMJ

A living WHO guideline on drugs to prevent covid-19 | The BMJ

Covid-19: Norway investigates 23 deaths in frail elderly patients after vaccination | The BMJ